Skip to Content

'
Janice N. Cormier, M.D., M.P.H., F.A.C.S.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Adjunct Faculty, Division of Management, Policy and Community Health, The University of Texas School of Public Health, Houston, TX

Education & Training

Degree-Granting Education

2002 Harvard School of Public Health, Boston, MA, MPH, Clinical Effectiveness
1991 University of Massachusetts Medical School, Worcester, MA, MD, Medicine
1986 Rensselaer Polytechnic Institute, Troy, NY, BS, Biology/Biochemistry

Board Certifications

12/2008 American Board of Surgery

Experience/Service

Academic Appointments

Assistant Professor, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 12/2002-8/2007
Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 7/2002-8/2007
Junior Faculty Associate, Department of Surgical Oncology, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 7/1999-6/2002

Military or Other Governmental Service

Lieutenant-Commander, United States Public Health Service, 6/1994-6/1997

Institutional Committee Activities

Member, Credentials Committee of the Medical Staff (CCMS), 9/2008-8/2011
Member, Quality of Life Advisory Committee, 2005-present

Honors and Awards

2008 Outstanding Teaching Award for Research, Surgical Oncology Fellows, UT M.D. Anderson Cancer Center
2007-2008 Texas Best Doctors in America Award, Best Doctors, Inc.
2007 Outstanding Contribution to the Field of Lymphedema, Lymphedema "D" Day Award, National Lymphedema Network
2006 Excellent Review Award, Office of Protocol Research, UT M.D. Anderson Cancer Center
2006 Outstanding Contribution to the Field of Lymphedema, Lymphedema "D" Day Award, National Lymphedema Network
2003 Career Development Award, American Society of Clinical Oncology
1999 Outstanding Woman Surgeon, Chief Resident Award, Association of Women Surgeons

Professional Memberships

American Association for Cancer Research
Active Member, 1999-present
American College of Surgeons
Fellow, 2004-present
American College of Surgeons Oncology Group
Member, 2003-present
American Lymphedema Framework Project (ALFP), Columbia, MO
Executive Director, 10/2008-present
American Public Health Association
Member, 2003-present
American Society of Clinical Oncology
Working Group on Communication Skills Training, 2008-present
Lifelong Learning Subcommittee of the Professional Development Committee, 2007-2010
Member, 1999-present
Association of Women Surgeons
Member, 1998-present
Connective Tissue Oncology Society
Member, 1999-present
Drug Information Association
Member, 1999-present
H. William Scott Society
Member, 1999-present
Harris County Medical Society, Houston, TX
Member, 2007-present
International Lymphoedema Framework (ILF) International Advisory Board (IAB), Columbia, MO
Member, 4/2009-present
International Society for Pharmacoeconomics and Outcomes Research
Member, 2003-present
International Society for Quality of Life Research
Member, 2003-present
National Lymphedema Network (NLN)
Co-Director, Lymphedema Task Force, 8/2008
Scientific Program Committee, 2006-present
Medical Advisory Committee, Chair, 2005-2009
Medical Advisory Committee, 2004-present
Member, 2004-present
Research Committee, 2004-present
Society for Melanoma Research
Member, 2004-present
Society of Clinical Trials
Member, 2000-present
Society of Medical Decision Making
Member, 2001-present
Society of Surgical Oncology
Outcomes Research Committee, 2009-2010
Outcomes Research Committee, 2008-2009
Outcomes Research Task Force, 2007-2008
Active Member, 2004-present
Clinical Affairs Committee, 2004-2007
Society of University Surgeons
Committee on Publications, 1/2009-present
Program Committee, 2008-2009
Member, 2005-present
Texas Medical Association, Austin, TX
Member, 2007-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Badgwell BD, Smith K, Liu P, Bruera E, Curley SA, Cormier JN. Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation. Support Care Cancer 17(6):727-34, 6/2009. PMID: 19083026.
2. Shih YCT, Xu Y, Cormier JN, Giordano S, Ridner S, Buchholz T, Perkins G, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: A two-year follow up study. J Clin Oncol 27(12):2007-14, 4/2009.
3. Beadle BM, Guadagnolo BA, Ballo MT, Lee JE, Gershenwald JE, Cormier JN, Mansfield PF, Ross MI, Zagars GK. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 73(5):1376-82, 4/2009.
4. Badgwell B, Cormier JN, Xing Y, Yao J, Bose D, Krishnan S, Pisters P, Feig B, Mansfield P. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol 16(1):42-50, 1/2009. PMID: 18985270.
5. Anaya DA, Lahat G, Liu J, Xing Y, Cormier JN, Pisters PW, Lev DC, Pollock RE. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 249(1):137-42, 1/2009. PMID: 19106689.
6. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, Pisters PW, Feig B, Mansfield P. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival. Ann Surg Oncol 15(10):2684-91, 10/2008. PMID: 18649106.
7. Wong SL, McCahill LE, Edge SB, Askew RL, Beitsch PD, Kollmorgen DR, Anthony T, Petrelli NJ, Leong SP, Cormier JN. Getting to better cancer care: results of a society of surgical oncology survey. Ann Surg Oncol 15(9):2363-71, 9/2008. PMID: 18470568.
8. Gershenwald JE, Andtbacka RH, Prieto VG, Johnson MM, Diwan AH, Lee JE, Mansfield PF, Cormier JN, Schacherer CW, Ross MI. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 26(26):4296-303, 9/2008. PMID: 18606982.
9. Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG. Phase II trial of Imatinib Mesylate in patients with metastatic melanoma. Br J Cancer 99(5):734-40, 9/2008. PMID: 18728664.
10. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Staging of breast cancer in the neoadjuvant setting. Cancer Res 68(16):6477-81, 8/2008. PMID: 18701468.
11. Badgwell BD, Cormier JN, Wray CJ, Borthakur G, Qiao W, Rolston KV, Pollock RE. Challenges in surgical management of abdominal pain in the neutropenic cancer patient. Ann Surg 248(1):104-9, 7/2008. PMID: 18580213.
12. Mortenson MM, Xing Y, Weaver S, Lee JE, Gershenwald JE, Lucci A, Mansfield PF, Ross MI, Cormier JN. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311). World J Surg Oncol 6:63, 6/2008. PMCID: PMC2464595.
13. Anaya DA, Xing Y, Feng L, Huang X, Camacho LH, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Cormier JN. Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with micrometastatic nodal disease. Cancer 112:2030-37, 2008.
14. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26(2):246-52, 2008. e-Pub 12/3/2007. PMID: 18056680.
15. Liu L, Coker AL, Du XL, Cormier JN, Ford CE, Fang S. Long-term survival after radical prostatectomy compared to other treatments in older men with local or regional prostate cancer. J Surg Oncol 97:583-91, 2008.
16. Al-Refaie WB, Andtbacka RH, Ensor J, Pisters PW, Ellis TL, Shrout A, Hunt KK, Cormier JN, Pollock RE, Feig BW. Lymphadenectomy for isolated lymph node metastasis from extremity soft tissue sarcomas. Cancer 112(8):1821-26, 2008. PMID: 18306370.
17. Badgwell BD, Camp ER, Feig B, Wolff RA, Eng C, Ellis LM, Cormier JN. Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol 19(3):577-82, 2008. e-Pub 11/16/2007. PMID: 18024857.
18. Mittendorf EA, Lim SJ, Schacherer CW, Lucci A, Cormier JN, Mansfield PF, Gershenwald JE, Ross MI, Lee JE. Melanoma adrenal metastasis: natural history and surgical management. Am J Surg 195(3):63-8, 2008. PMID: 18206850.
19. Cormier JN, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Camacho LH, Kim K, Webster K, Cella D, Palmer JL. Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer therapy-melanoma (FACT-melanoma) questionnaire. Cancer 112:2249-57, 2008.
20. Heller L, Ballo MT, Cormier JN, Oates S, Butler CE. Staged reconstruction for wounds in sarcoma patients treated with brachytherapy. Ann Plast Surg 60:58-63, 2008.
21. Cormier JN, Xing Y, Ding M, Cantor SB, Salter KJ, Lee JE, Mansfield PF, Gershenwald JE, Ross MI. Cost effectiveness of adjuvant interferon in node-positive melanoma. J Clin Oncol 25:2442-8, 6/2007. PMID: 17557957.
22. Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin RS, Griffin JR, Chase JL, Pisters PW, Pollock RE, Hunt KK. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol 14. e-Pub 5/2007. PMID: 17541691.
23. Torres MA, Ballo MT, Butler CE, FEig BW, Cormier JN, Lewis VO, Pollock RE, Pisters PW, Zagars GK. Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys 67:1124-9, 3/2007. PMID: 17208389.
24. Li C, Liu Z, Zhang Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei Q. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol 127:276-80, 2/2007. PMID: 16990805.
25. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67:158-63, 1/2007. PMID: 17084545.
26. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14:14-24, 1/2007. PMID: 17072676.
27. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian I. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110:2542-50, 2007.
28. Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246:675-81, 2007.
29. Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Pelvic lymph node dissection is beneficial in subjects of patients with node-positive melanoma. Annals Surg Oncol 14:2867-75, 2007. PMID: 17671814.
30. Gannon CJ, Rousseau DL, Jr, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Cancer 107:2647-52, 12/2006. PMID: 17063497.
31. Li C, Hu Z, Liu Z, Wang LE, Strom SS, Gershenwald JE, Lee JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei Q. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev 15:2526-32, 12/2006. PMID: 17164380.
32. Jeruss JS, Hunt KK, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Cormier JN. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective. Cancer 107:2328-36, 11/2006. PMID: 17039501.
33. Huang X, Cormier JN, Pisters PW. Estimation of the causal effects on survival of two-stage nonrandomized treatment sequences for recurrent diseases. Biometrics 62:901-9, 9/2006. PMID: 16984334.
34. Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 166:1907-14, 9/2006. PMID: 17000949.
35. Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, Cannon CP, Zagars GK, Pollock RE, Pisters PW. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 13:1209-15, 9/2006. PMID: 16952046.
36. Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE, Ross MI, Cormier JN. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 13:902-9, 7/2006. PMID: 16788750.
37. Aloia TA, Gershenwald JE, Andtbacka RH, Johnson MM, Schacherer CW, Ng CS, Cormier JN, Lee JE, Ross MI, Mansfield PF. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol 24:2858-65, 6/2006. PMID: 16782925.
38. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539-46, 5/2006. PMID: 16329089.
39. Cormier JN, Xing Y, Feng L, Huang X, Davidson L, Gershenwald JE, Lee JE, Mansfield PF, Ross MI. Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer 106:2012-20, 5/2006. PMID: 16568458.
40. Li C, Liu Z, Wang LE, Strom SS, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei Q. Genetic variants of the ADPRT, XRCC1, and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 27:1894-1901, 4/2006. PMID: 16621887.
41. Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O'Sullivan B, Pollock RE, Swallow CJ. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13:508-17, Mar-Apr, 4/2006. PMID: 16491338.
42. Li C, Larson D, Zhang Z, Liu Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei Q. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 16:253-63, Mar-Apr, 4/2006. PMID: 16538172.
43. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 106:1276-85, Mar-Apr, 3/2006. PMID: 16475208.
44. Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer 106:900-6, 2/2006. PMID: 16411225.
45. Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, Hwu P, Zagars GK. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 64:106-13, Mar-Apr, 2006. PMID: 16182463.
46. Cormier JN, Thomas KT, Chari RS, Pinson CW. Management of hepatocellular carcinoma. J Gastrointest Surg 10:761-80, 2006.
47. Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J, Burgess M, Patel S, Pollock RE, Cormier JN. Angiosarcoma of the breast. Cancer 104:2682-8, Mar-Apr, 12/2005. PMID: 16288486.
48. Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 97:1822-31, Mar-Apr, 12/2005. PMID: 16368944.
49. Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 23:6054-62, Mar-Apr, 9/2005. PMID: 16135473.
50. Pawlik TM, Ross MI, Johnson MM, Schacherer CW, McClain DM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 12:587-96, 8/2005. PMID: 16021533.
51. Cormier JN, Davidson L, Xing Y, Webster K, Cella D. Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale. J Support Oncol 3:139-45, Mar-Apr, 3/2005. PMID: 15796446.
52. Cormier JN, Huang X, Xing Y, Thall PF, Wang X, Benjamin RS, Pollock RE, Antonescu CR, Maki RG, Brennan MF, Pisters PW. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 22:4567-74, Mar-Apr, 11/2004. PMID: 15542808.
53. Xing Y, Cormier JN, Kuerer HM, Hunt KK. Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management. Asian J Surg 27:262-7, Mar-Apr, 10/2004. PMID: 15564176.
54. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 58:1461-7, Mar-Apr, 4/2004. PMID: 15050324.
55. Cormier JN, Xing Y, Ross MI, Cantor SB. Interferon-alpha in high-risk melanoma patients. Exp Rev Pharmacoeco and Outcomes Res 4:667-676, 2004.

Grant & Contract Support

Title: Effective surveillance strategies for melanoma patients
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 12/1/2008 - 11/30/2009
 
Title: Postmarking Surveillance of Toxicities Associated with Cancer Chemotherapy
Funding Source: Agency for Healthcare Research and Quality (AHRQ)
Role: Collaborator
Principal Investigator: Xianglin L. Du, M.D., Ph.D.
Duration: 4/1/2007 - 3/31/2011
 
Title: Assessing outcomes in patients with melanoma
Funding Source: NIH
Role: Principal Investigator-MDACC
Principal Investigator: Robert Bast, M.D.
Duration: 9/1/2003 - 8/31/2006
 
Title: Development of a Markov decision model for patients with melanoma
Funding Source: American Society of Clinical Oncology
Role: Principal Investigator
Duration: 7/1/2003 - 6/30/2006
 
Title: Outcomes by Ethnicity: Sentinel lymph node status in women with breast cancer
Funding Source: Department of Defense (DOD)
Role: Collaborator
Principal Investigator: Mary Alice Hassett, B.S.N., R.N.
Duration: 7/27/2000 - 4/23/2007

Last updated: 9/16/2009